R1 RCM Inc. with ticker code (RCM) now have 15 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $20.00 and $14.00 suggesting an average Analsyt target price of $16.93. Given that the stocks previous close was at $12.15 this would indicate that there is a potential upside of 39.3%. The 50 day moving average now sits at $12.65 while the 200 day moving average is $13.20. The total market capitalization for the company now stands at 5.06B. The stock price for the company is currently $12.02 USD
The potential market cap would be $7,046,746,071 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 1202, revenue per share of $5.39 and a 3.29% return on assets.
R1 RCM Holdco Inc., formerly R1 RCM Inc., is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also improving patient, physician, and staff satisfaction for its customers. Its primary service offering consists of RCM services for health systems, hospitals, and physician groups. It also offers modular services, allowing customers to engage for only specific components of its end-to-end RCM service offering, such as physician advisory services (PAS), practice management (PM), revenue integrity solutions (RIS), patient experience (PX), coding management, and business office services. Its PAS offering assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes.
